These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10326547)

  • 61. Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer.
    Ferrari AC; Stone NN; Eyler JN; Gao M; Mandeli J; Unger P; Gallagher RE; Stock R
    J Natl Cancer Inst; 1997 Oct; 89(20):1498-504. PubMed ID: 9337346
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction.
    Kusuda Y; Miyake H; Kurahashi T; Fujisawa M
    Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.
    Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW
    Prostate; 2003 Jun; 55(4):308-16. PubMed ID: 12712410
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11.
    Rinker-Schaeffer CW; Hawkins AL; Su SL; Israeli RS; Griffin CA; Isaacs JT; Heston WD
    Genomics; 1995 Nov; 30(1):105-8. PubMed ID: 8595888
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen.
    Gong MC; Latouche JB; Krause A; Heston WD; Bander NH; Sadelain M
    Neoplasia; 1999 Jun; 1(2):123-7. PubMed ID: 10933046
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative.
    Gao M; Ossowski L; Ferrari AC
    J Cell Physiol; 1999 Jun; 179(3):336-46. PubMed ID: 10228952
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Next revolution in molecular theranostics: personalized medicine for urologic cancers.
    Aoun F; Kourie HR; Artigas C; Roumeguère T
    Future Oncol; 2015; 11(15):2205-19. PubMed ID: 26235183
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeted elimination of prostate cancer by genetically directed human T lymphocytes.
    Gade TP; Hassen W; Santos E; Gunset G; Saudemont A; Gong MC; Brentjens R; Zhong XS; Stephan M; Stefanski J; Lyddane C; Osborne JR; Buchanan IM; Hall SJ; Heston WD; Rivière I; Larson SM; Koutcher JA; Sadelain M
    Cancer Res; 2005 Oct; 65(19):9080-8. PubMed ID: 16204083
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
    Liu R; Sun J; Zhang Z; Xu Y
    Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prostate-specific membrane antigen: evidence for the existence of a second related human gene.
    Leek J; Lench N; Maraj B; Bailey A; Carr IM; Andersen S; Cross J; Whelan P; MacLennan KA; Meredith DM
    Br J Cancer; 1995 Sep; 72(3):583-8. PubMed ID: 7669565
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line.
    Christiansen JJ; Rajasekaran SA; Moy P; Butch A; Goodglick L; Gu Z; Reiter RE; Bander NH; Rajasekaran AK
    Prostate; 2003 Apr; 55(1):9-19. PubMed ID: 12640656
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Monoclonal antibody therapy for prostate cancer: finally a reality?
    Small EJ
    J Clin Oncol; 2004 Jul; 22(13):2515-6. PubMed ID: 15173211
    [No Abstract]   [Full Text] [Related]  

  • 73. Ipilimumab in the treatment of prostate cancer.
    Reese Z; Straubhar A; Pal SK; Agarwal N
    Future Oncol; 2015; 11(1):27-37. PubMed ID: 25572782
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prostate-specific membrane antigen is produced in tumor-associated neovasculature.
    Chang SS; O'Keefe DS; Bacich DJ; Reuter VE; Heston WD; Gaudin PB
    Clin Cancer Res; 1999 Oct; 5(10):2674-81. PubMed ID: 10537328
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential expression of cell surface molecules in prostate cancer cells.
    Liu AY
    Cancer Res; 2000 Jul; 60(13):3429-34. PubMed ID: 10910052
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer.
    Beckett ML; Cazares LH; Vlahou A; Schellhammer PF; Wright GL
    Clin Cancer Res; 1999 Dec; 5(12):4034-40. PubMed ID: 10632336
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PSMA mimotope isolated from phage displayed peptide library can induce PSMA specific immune response.
    Zhu ZY; Zhong CP; Xu WF; Lin GM; Ye GQ; Ji YY; Sun B; Yeh M
    Cell Res; 1999 Dec; 9(4):271-80. PubMed ID: 10628836
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.
    Lupold SE; Hicke BJ; Lin Y; Coffey DS
    Cancer Res; 2002 Jul; 62(14):4029-33. PubMed ID: 12124337
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic factors in prostate and testis cancer.
    Van Brussel JP; Mickisch GH
    BJU Int; 1999 May; 83(8):910-6; quiz 916-7. PubMed ID: 10368228
    [No Abstract]   [Full Text] [Related]  

  • 80. Prostate-specific membrane antigen-mediated theragnostics in prostate cancer.
    Jeong SH; Kwak C
    Investig Clin Urol; 2021 Sep; 62(5):497-499. PubMed ID: 34488249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.